235 related articles for article (PubMed ID: 28183653)
1. Synthesis, characterization and augmented anticancer potential of PEG-betulinic acid conjugate.
Saneja A; Sharma L; Dubey RD; Mintoo MJ; Singh A; Kumar A; Sangwan PL; Tasaduq SA; Singh G; Mondhe DM; Gupta PN
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():616-626. PubMed ID: 28183653
[TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
[TBL] [Abstract][Full Text] [Related]
3. Antitumor drug effect of betulinic acid mediated by polyethylene glycol modified liposomes.
Liu Y; Gao D; Zhang X; Liu Z; Dai K; Ji B; Wang Q; Luo L
Mater Sci Eng C Mater Biol Appl; 2016 Jul; 64():124-132. PubMed ID: 27127036
[TBL] [Abstract][Full Text] [Related]
4. Betulinic acid induces apoptosis and inhibits metastasis of human colorectal cancer cells in vitro and in vivo.
Zeng A; Hua H; Liu L; Zhao J
Bioorg Med Chem; 2019 Jun; 27(12):2546-2552. PubMed ID: 30910472
[TBL] [Abstract][Full Text] [Related]
5. Betulinic acid induces apoptosis and inhibits metastasis of human renal carcinoma cells in vitro and in vivo.
Yang C; Li Y; Fu L; Jiang T; Meng F
J Cell Biochem; 2018 Nov; 119(10):8611-8622. PubMed ID: 29923216
[TBL] [Abstract][Full Text] [Related]
6. Self assembled nano fibers of betulinic acid: A selective inducer for ROS/TNF-alpha pathway mediated leukemic cell death.
Dash SK; Chattopadhyay S; Dash SS; Tripathy S; Das B; Mahapatra SK; Bag BG; Karmakar P; Roy S
Bioorg Chem; 2015 Dec; 63():85-100. PubMed ID: 26469741
[TBL] [Abstract][Full Text] [Related]
7. Self-assembled betulinic acid protects doxorubicin induced apoptosis followed by reduction of ROS-TNF-α-caspase-3 activity.
Dash SK; Chattopadhyay S; Ghosh T; Dash SS; Tripathy S; Das B; Bag BG; Das D; Roy S
Biomed Pharmacother; 2015 May; 72():144-57. PubMed ID: 26054689
[TBL] [Abstract][Full Text] [Related]
8. Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid.
Godugu C; Patel AR; Doddapaneni R; Somagoni J; Singh M
PLoS One; 2014; 9(3):e89919. PubMed ID: 24614362
[TBL] [Abstract][Full Text] [Related]
9. p53-p66(shc)/miR-21-Sod2 signaling is critical for the inhibitory effect of betulinic acid on hepatocellular carcinoma.
Yang J; Qiu B; Li X; Zhang H; Liu W
Toxicol Lett; 2015 Nov; 238(3):1-10. PubMed ID: 26222667
[TBL] [Abstract][Full Text] [Related]
10. Targeting mitochondrial apoptosis by betulinic acid in human cancers.
Fulda S; Kroemer G
Drug Discov Today; 2009 Sep; 14(17-18):885-90. PubMed ID: 19520182
[TBL] [Abstract][Full Text] [Related]
11. Betulinic acid: a natural product with anticancer activity.
Fulda S
Mol Nutr Food Res; 2009 Jan; 53(1):140-6. PubMed ID: 19065582
[TBL] [Abstract][Full Text] [Related]
12. Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells.
Rzeski W; Stepulak A; Szymański M; Sifringer M; Kaczor J; Wejksza K; Zdzisińska B; Kandefer-Szerszeń M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Oct; 374(1):11-20. PubMed ID: 16964520
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and cytotoxic activity of heterocyclic ring-substituted betulinic acid derivatives.
Kumar V; Rani N; Aggarwal P; Sanna VK; Singh AT; Jaggi M; Joshi N; Sharma PK; Irchhaiya R; Burman AC
Bioorg Med Chem Lett; 2008 Sep; 18(18):5058-62. PubMed ID: 18752941
[TBL] [Abstract][Full Text] [Related]
14. Betulinic acid inhibits autophagic flux and induces apoptosis in human multiple myeloma cells in vitro.
Yang LJ; Chen Y; He J; Yi S; Wen L; Zhao J; Zhang BP; Cui GH
Acta Pharmacol Sin; 2012 Dec; 33(12):1542-8. PubMed ID: 23064721
[TBL] [Abstract][Full Text] [Related]
15. Characterization and in vitro studies of the anticancer effect of oxidized carbon nanotubes functionalized with betulinic acid.
Tan JM; Karthivashan G; Arulselvan P; Fakurazi S; Hussein MZ
Drug Des Devel Ther; 2014; 8():2333-43. PubMed ID: 25429205
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of phosphotidylinositol-3 kinase pathway by a novel naphthol derivative of betulinic acid induces cell cycle arrest and apoptosis in cancer cells of different origin.
Majeed R; Hamid A; Sangwan PL; Chinthakindi PK; Koul S; Rayees S; Singh G; Mondhe DM; Mintoo MJ; Singh SK; Rath SK; Saxena AK
Cell Death Dis; 2014 Oct; 5(10):e1459. PubMed ID: 25299784
[TBL] [Abstract][Full Text] [Related]
17. [Advances in the study of structural modifications and biological activities of betulinic acids].
Lan P; Zhang DM; Chen WM; Ye WC
Yao Xue Xue Bao; 2010 Nov; 45(11):1339-45. PubMed ID: 21361032
[TBL] [Abstract][Full Text] [Related]
18. Betulinic acid triggers apoptosis and inhibits migration and invasion of gastric cancer cells by impairing EMT progress.
Chen Y; Wu X; Liu C; Zhou Y
Cell Biochem Funct; 2020 Aug; 38(6):702-709. PubMed ID: 32283563
[TBL] [Abstract][Full Text] [Related]
19. Betulinic acid: a new cytotoxic compound against malignant head and neck cancer cells.
Thurnher D; Turhani D; Pelzmann M; Wannemacher B; Knerer B; Formanek M; Wacheck V; Selzer E
Head Neck; 2003 Sep; 25(9):732-40. PubMed ID: 12953308
[TBL] [Abstract][Full Text] [Related]
20. Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid.
Qiu L; Wang Q; Di W; Jiang Q; Schefeller E; Derby S; Wanebo H; Yan B; Wan Y
Int J Oncol; 2005 Sep; 27(3):823-30. PubMed ID: 16077934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
